ELV
Elevance Health, Inc.
Stock
$386.43+4.76 (+1.25%)Close Oct 2, 2026
- Operating cash flow, 2025
- $4.3B
- YoY, 2025
- −26.1%
- 5-year CAGR
- −16.7%
- 10-year CAGR
- +0.2%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $4.3B | −26.1% |
| 2024 | $5.8B | −27.9% |
| 2023 | $8.1B | −4.0% |
| 2022 | $8.4B | +0.4% |
| 2021 | $8.4B | −21.7% |
| 2020 | $10.7B | +76.3% |
| 2019 | $6.1B | +58.4% |
| 2018 | $3.8B | −8.6% |
| 2017 | $4.2B | +28.0% |
| 2016 | $3.3B | −22.4% |
| 2015 | $4.2B | +25.0% |
| 2014 | $3.4B | +10.4% |
| 2013 | $3.1B | +11.2% |
| 2012 | $2.7B | −18.7% |
| 2011 | $3.4B | +138.2% |
| 2010 | $1.4B | −53.4% |
| 2009 | $3.0B | +19.9% |
| 2008 | $2.5B | −41.6% |
| 2007 | $4.3B | — |